News & Events about Cerus Corp.
BTIG Research cut shares of Cerus (NASDAQ:CERS Get Rating) from a buy rating to a neutral rating in a research note published on Friday morning, MarketBeat Ratings reports. CERS has been the subject of several other research reports. Stephens lowered Cerus from an overweight rating to an equal ...
Cerus Corporation (Nasdaq: CERS) today announced preliminary product revenue for the fourth quarter and full-year 2022 and provided product revenue guidance for full-year 2023. Cerus unaudited preliminary product revenue for the fourth quarter of 2022 totaled $44.0 million, representing an increase...
Business Wire
3 months ago
Cerus Corporation (Nasdaq: CERS) announced today that Vivek Jayaraman, Cerus chief operating officer, is scheduled to participate in two conferences: The Stifel 2022 Healthcare Conference on Wednesday, November 16th at 1:50 p.m. EST, at the Lotte New York Palace Hotel. The Stephens Annual...
Business Wire
3 months ago
Cerus Corporation (Nasdaq: CERS) today announced that it has been awarded a $9.1 million contract by the U.S. Department of Defense (DoD) Industrial Base Analysis and Sustainment (IBAS) program for the development of pathogen reduced, lyophilized cryoprecipitate (LyoCryo) to treat bleeding due to...
Business Wire
4 months ago
Cerus Corporation (Nasdaq:CERS) today announced a selection of abstracts and an industry workshop at the 2022 AABB Annual Meeting, taking place in Orlando, FL from October 1 through October 4. This years AABB Annual Meeting attracts individuals and institutions from around the globe involved in the...